scholarly journals A 1-Year Cost Analysis of Spinal Surgical Procedures in Spain: Neurosurgeons Versus Orthopedic Surgeons

Neurospine ◽  
2019 ◽  
Vol 16 (2) ◽  
pp. 354-359 ◽  
Author(s):  
Martín Avellanal ◽  
Mónica Martin-Corvillo ◽  
Laura Barrigon ◽  
Manuel Vazquez Espi ◽  
Clara M. Esteban Escolar
Neurospine ◽  
2019 ◽  
Vol 16 (2) ◽  
pp. 23-28
Author(s):  
Martín Avellanal ◽  
Mónica Martin-Corvillo ◽  
Laura Barrigon ◽  
Manuel Vazquez Espi ◽  
Clara M. Esteban Escolar

2017 ◽  
Vol 9 ◽  
pp. 172
Author(s):  
Bambang Dwipoyono ◽  
Septyana Choirunisa ◽  
Mardiati Nadjib ◽  
Amal C Sjaaf

Objective: This exploratory study aimed to evaluate and compare the treatment costs of taxane-based versus cisplatin-based chemotherapy.Methods: This study used data from the medical and financial records of ovarian cancer patients who were admitted to Dharmais NationalCancer Hospital (RSKD) between 2008 and 2012 and subsequently underwent surgery and were treated with chemotherapy. Data were analyzedusing descriptive analysis, and a Kaplan–Meier graph was plotted to compare the survival of the patients in the taxane-based and cisplatin-basedchemotherapy groups.Results: Of 41 patients, treatment costs were available for nine patients who had undergone taxane-based chemotherapy and for 31 patients who hadundergone cisplatin-based chemotherapy. In general, surgical procedures accounted for the highest proportion of the treatment costs, followed bychemotherapy. Taxane-based chemotherapy (six cycles) was 4 times more expensive than cisplatin-based therapy. The pre- and post-chemotherapycosts of care among those treated with the taxane-based regimen were 3-4 times more expensive than those of the patients who received cisplatinbasedtreatment. The disease-free recurrence duration of the patients treated with taxane was longer (median=18 months) than that of the patientstreated with cisplatin (median=5 months).Conclusions: Taxane-based therapy increased the disease-free recurrence duration of the patients, with disease-free recurrence 3 times longer thanthat of the patients treated with the cisplatin-based regimen. However, the treatment costs of the taxane-based regimen were 4 times higher thanthose of the cisplatin-based treatment.


1998 ◽  
Vol 383 (5) ◽  
pp. 359-363 ◽  
Author(s):  
J. Bruns ◽  
S. Luessenhop ◽  
P. Behrens

2018 ◽  
Vol 53 (1) ◽  
pp. 81-85 ◽  
Author(s):  
Jacob K. Olson ◽  
Lisa A. Deming ◽  
Denis R. King ◽  
Terrence M. Rager ◽  
Sarah Gartner ◽  
...  

2020 ◽  
Vol 9 (1) ◽  
pp. LMT28
Author(s):  
Dolores Isla ◽  
Bartomeu Massuti ◽  
Martín Lázaro ◽  
Lucía Ruiz de Alda ◽  
Rocio Gordo ◽  
...  

Aim: To estimate management cost of NSCLC ALK+ patients with and without brain metastasis (BM), and to compare annual costs in patients treated with alectinib or crizotinib. Methods: Management cost/year (€ 2018) in patients with and without BM was estimated with disaggregated resource consumption provided by local oncologists, including medical visits, hospitalizations, diagnostic/laboratory tests, imaging techniques and surgical procedures. The comparison of costs/year with alectinib and crizotinib, considered the cumulative 12-month incidence of BM in ALEX trial (9.4 and 41.4%, respectively). Results: Management cost was €6173.42/patient-year without BM and €21,637.50/patient-year with BM. With alectinib, average cost/patient was lower than crizotinib (€4948.51/patient-year) Conclusion: Prevention of BM with alectinib may result in reductions of cost/year in the management of advanced ALK+ NSCLC.


Author(s):  
Joaquin Sanchez-Sotelo

Most orthopedic surgeons, and even many shoulder experts, are a little intimidated by the evaluation and management of patients with conditions affecting the scapula, periscapular muscles, and scapulothoracic joint. Explanations for this include relative unfamiliarity with the anatomy, function, physical examination, and diagnostic categories related to the scapula, and the fact that surgical procedures around the scapula are not performed commonly. Dysfunction of the scapulothoracic joint may play a major role in patients with diverse shoulder conditions such as disorders of the clavicle and the acromioclavicular joint, shoulder instability, and rotator cuff disease. Additionally, the scapulothoracic joint and periscapular muscles may be affected by disorders such as traumatic muscle avulsions, injuries to various nerves, fractures of the scapula and the glenoid cavity, bursitis, osteochondromas, and congenital abnormalities. Finally, some patients present with pain and dysfunction secondary to poor control of the periscapular muscles in the absence of specific structural pathology.


2009 ◽  
Vol 106 (S 04) ◽  
pp. S71-S74
Author(s):  
O. Thomusch ◽  
A. Machens ◽  
C. Matuschka ◽  
H. Dralle

2021 ◽  
Vol 8 (4) ◽  
pp. 314-319
Author(s):  
Anjalee G Ovhal ◽  
K Ravikumar ◽  
Devender Sachdev

The knowledge of variable branching pattern of Axillary artery is needed for vascular surgeons, onco surgeons, anaesthesiologists, orthopedic surgeons and radiologists due to increased use of invasive diagnostic, interventional procedures. The aim was to study the variable branching pattern of Axillary artey in cadavers. 15 cadavers (30 upper limbs) - 12 male and 3 female embalmed with 10% formalin were dissected for this study. Variable branching pattern was observed in 6.6% of the cases on right side and 6.6% of the cases on left side in first part of axillary artery, 40% of the cases on right side and 53.3% of the cases on left side in second part and 53.3% of the cases on right side and 26.6% of the cases on left side in third part. The anatomical knowledge of the normal and variant anatomy of the Axillary artery is of importance for anatomists, surgeons, radiologists and clinicians during various interventional, diagnostic, therapeutic and surgical procedures on pectoral and axillary regions.


Sign in / Sign up

Export Citation Format

Share Document